SGLT-2 inhibitors as second-line therapy in type 2 diabetes

Abd A. Tahrani*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)678-679
Number of pages2
JournalThe Lancet Diabetes and Endocrinology
Issue number9
Early online date16 Jun 2014
Publication statusPublished - Sept 2014

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology
  • General Medicine

Cite this